Code | Description |
---|---|
J9037 | Injection, belantamab mafodotin-blmf, 0.5 mg |
Drug common name | Mafodotin |
INN | belantamab mafodotin |
Description | Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of the approved drug belantamab mafodotin in multiple myeloma and some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody.
|
Classification | Small molecule |
Drug class | synthetic analogs of the dolastatin series |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN1C(=O)C=CC1=O)C(C)C |
PDB | — |
CAS-ID | 745017-94-1 |
RxCUI | — |
ChEMBL ID | CHEMBL2107813 |
ChEBI ID | — |
PubChem CID | 10395173 |
DrugBank | — |
UNII ID | DB1041CXDG (ChemIDplus, GSRS) |